Qualified laboratory research use only. Not for human or veterinary use, consumption, administration, compounding, diagnosis, or treatment.
Research use only
FOXO4-DRI
10 mgCatalog SKU: VP-FOXO4-10
- COA records listed
- Lot identifier listed
- Research use only
BTC, ETH, USDC, and USDT accepted. View crypto payment steps.
Credit/debit card · Secure Bank Payment · Cash App · Venmo · Zelle
Use WELCOME20 for 20% off one eligible first order. Free FedEx tracked U.S. shipping on a $200+ pre-discount merchandise subtotal; $5 Kansas local delivery.Product details
Catalog and Buyer Notice
FOXO4-DRI (10mg vials) is cataloged solely as a laboratory research material for qualified procurement, analytical review, and institutional recordkeeping.
Confirm the product label, SKU, selected strength, lot or batch identifier, and available COA/specification record before ordering and again upon receipt.
Vespera does not provide dosing, preparation-for-administration, protocol, clinical, medical, veterinary, or personal-use guidance. Orders may be declined when buyer qualification or intended use cannot be verified.
Specifications
Catalog specifications
| Catalog product | FOXO4-DRI (10mg vials) |
|---|---|
| Listed form | Lyophilized research vial |
| Listed analytical result | 99.92% |
| Lot / batch | 2026-05-06 gray cap |
| SKU | VP-FOXO4-10 |
| Availability | Available |
Analytical fields summarize the catalog record only. Review the matching published lot-specific document for method, sample, and result details. Contact support if the matching record is missing or unclear.
Qualified procurement
Laboratory handling and records
Buyer qualification: Buyers must be at least 21 and purchasing for qualified in vitro laboratory research. Vespera may request affiliation or intended-use information and may decline an order.
Storage record: Keep sealed material under the lot-specific conditions stated in the applicable documentation. Do not rely on a general web statement in place of the batch record.
Institutional controls: Qualified personnel are responsible for validated SOPs, appropriate facilities, safety controls, chain of custody, and lawful disposition.
No use instructions: This catalog does not provide dosing, reconstitution for administration, injection, route-of-use, or human or veterinary protocol guidance.
Orders are subject to buyer, inventory, and compliance review.
Lot / COA
Lot documentation and specifications
Documentation: Browse the COA catalog and match product, SKU, lot, method, and result to the item received. Contact support if the matching record is missing or unclear.
Listed lot / batch: 2026-05-06 gray cap
Listed analytical result: 99.92%
- FOXO4-DRI 10mg COA VP-FOXO4-10
Ordering and documentation
Information for qualified laboratory buyers reviewing this catalog record.
Who may order this material?
Buyers must be at least 21 and purchasing for qualified in vitro laboratory research. Vespera may request affiliation or intended-use information and may decline an order.
What should be reviewed before ordering?
Review the exact product name, SKU, selected strength, lot or batch information, listed analytical method, and available COA/specification documentation.
Does Vespera provide personal-use or administration guidance?
No. Vespera does not provide dosing, administration, injection, human-use, veterinary-use, clinical, medical, or personal-use guidance.
